Bistos Completes 3.5 Billion Won Rights Offering to Largest Shareholder, Diluting Existing Shareholders by 29.6%
Bistos completed the payment for a 3.5 billion won third-party allotment capital increase on June 18, 2026, targeting its largest shareholder CU Medical Systems.
A total of 1,359,751 new shares were issued at 2,574 won per share, resulting in a 29.6% dilution of existing shareholders' equity.
The proceeds will be allocated to facility investment for medical device production expansion of 2.5 billion won and working capital of 1.0 billion won, aiming to strengthen long-term growth foundations.
Although the largest shareholder has a one-year lock-up period limiting immediate selling pressure, the substantial dilution poses a downside risk to the stock price.
[AI Summary]Bistos has completed the capital increase from its largest shareholder, diluting existing shareholders by 29.6%. While the funds are directed towards production capacity expansion for long-term growth, the massive dilution is a negative factor for the stock price. The one-year lock-up mitigates short-term overhang but does not eliminate the structural dilution impact.
KOSDAQ Filing Information
Securities Issuance Result (Voluntary Disclosure) (Third-Party Allotment Rights Offering)